Chemokine-dependent migration of T lymphocytes assures recirculation of naïve T cells to secondary lymphoid organs and tissuespecific trafficking of memory-effector T cells. Previous studies carried out in rodents have demonstrated age-associated modulation of the expression of chemokine receptors such as CXCR4 and CCR5; however, little is known about the molecular mechanisms that regulate receptor expression and turnover in T cells, during advancing age in humans. Our recent results demonstrating increased chemotactic migration in response to CXCL12 in CD4 + T cells obtained from the elderly, as compared to those from young donors, led us to hypothesize that increase in surface expression, because of altered endocytic regulation of CXCR4 on T cells during aging, might be directly responsible for increased migration toward CXCL12. Studies presented here demonstrate a significant increase in the surface expression of CXCR4 in CD4 + T cells from elderly human donors, relative to those from the young. Additionally, CXCL12-mediated endocytosis of CXCR4 was differentially regulated during aging, which could be attributed to alterations in the ubiquitination of CXCR4. Thus, altered ubiquitination of CXCR4 may contribute to the increased surface expression and enhanced T-cell migration to chemotactic stimuli in the elderly.
Introduction
Studies have well documented that aging significantly attenuates the ability of an individual to mount appropriate immune responses (Arnold et al., 2011; Baum et al., 2011; Ponnappan & Ponnappan, 2011) . Most of the studies dealing with immunity during advancing age in humans have focused on the impact of age on antigen-specific TCR-repertoire diversity, antigenic reactivity, and T-cell-dependent antibody generation in response to vaccination (Caruso et al., 2005; Brunner et al., 2011; Deeks, 2011; den Elzen et al., 2011) , with only a limited number focusing on trafficking and ⁄ or chemotactic migration. Studies in murine models of aging that have reported on chemotactic migration, demonstrate a significantly higher response to the chemokine CXCL12 in T cells from aged mice than those from younger cohorts (Steeber et al., 1996; Stohlawetz et al., 1996; Toichi et al., 1997; Nyugen et al., 2010) . As migration and trafficking of memory and naïve T cells are critical to mounting an effective immune response, any defect in these properties is likely to negatively impact this ability. Therefore, understanding the impact of aging on chemokines and chemokine receptors in regulating migration is essential to delineating immune senescence.
Chemokines and chemokine receptors have been shown to exquisitely regulate T-cell migration (Estes et al., 2004; Contento et al., 2008; Bai et al., 2009; Booth et al., 2010; Bunting et al., 2011) . Among these receptors, CXCR4, a member of the G protein-coupled receptor (GPCR) family, has received a great deal of attention because of its vital role in T lymphocyte development, migration and cytokine secretion. The functions attributed to CXCR4 in T lymphocytes are linked to its surface expression, which is regulated by ligand-dependent endocytosis and degradation of the endocytosed receptor. Abnormal expression or function of CXCR4 has been reported in several diseases such as cancer, cardiovascular disease, inflammatory allergic disease, HIV, and neuroinflammatory disease (Feng et al., 1996; Abu El-Asrar et al., 2001; Rauer et al., 2002; Burger et al., 2003; Walter et al., 2005) . Ligand-dependent stimulation of CXCR4 has been demonstrated to result in endocytosis and degradation, following ubiquitination and lysosomal targeting. Three sites for ubiquitination have been identified on CXCR4 that are linked to lysosomal degradation (Marchese & Benovic, 2001; Marchese et al., 2003; Bhandari et al., 2007 Bhandari et al., , 2009 Malik & Marchese, 2010; Caballero & Marchese, 2011) . Interestingly, mono-ubiquitination of CXCR4 is not required for endocytosis and trafficking, but is essential for receptor degradation. Agonist-mediated activation appears to promote mono-ubiquitination and lysosomal degradation of CXCR4 in HEK293 cell line via a mechanism dependent on ubiquitin ligase, AIP4, (Marchese et al., 2003; Bhandari et al., 2009) . Indeed, activation of CXCR4 in HEK293 cells expressing catalytically inactive AIP4 mutants or depleted of AIP4 by siRNA, results in reduction, but not complete abrogation of ubiquitination and degradation. This partial inhibition of mono-ubiquitination and degradation allowed us to posit that other mechanisms, perhaps poly-ubiquitination by alternative ligases and proteasome-mediated degradation, may also be involved in CXCR4 regulation during aging (Lapham et al., 2002; Marchese, 2009; Berlin et al., 2010) . Support for this hypothesis is based on studies in which pretreatment with lactacystin, a cell-permeable proteasome-specific inhibitor, increased the surface expression of CXCR4 in T lymphocytes. Therefore, it is likely that CXCL12-induced CXCR4 internalization and ⁄ or degradation involves multiple lysine-dependent mono-ubiquitination or poly-ubiquitination events. Additionally, deubiquitination events, primarily attributed to USP14, appear to be critical in controlling ligand-dependent CXCR4 internalization, degradation, and chemotaxis. While it was reported that over-expression of USP14 followed by CXCL12 treatment resulted in a significant reduction in CXCR4-dependent migration (Mines et al., 2009) , little is known about the impact of USP14 inhibition on CXCR4 surface expression in T cells in general and specifically during aging. We now report that age-associated alteration in the expression of CXCR4 in T cells from the elderly appears to underlie increased migration observed in response to CXCL12. Employing a small molecule inhibitor of USP14 and analysis of ubiquitination of CXCR4, we now demonstrate age-associated alteration in the ubiquitination status of CXCR4, which may directly or indirectly regulate the expression and ⁄ or internalization of the receptor.
Results

CD4
+ T cells demonstrate increased surface expression of CXCR4 during aging.
As our previous studies clearly demonstrated that CD4 + T cells from the elderly have higher migratory index in response to CXCL12 (Cane et al., 2012) , we next evaluated the surface expression of CXCR4 in CD4 + T cells obtained from both young and elderly donors. Expression of CXCR4 was analyzed in primary human CD4 + T cells, as well as in CD4 + CD45RO + and RA + T-cell subsets, because aging is often accompanied by a shift in population of CD4 + naïve T cells to a predominantly CD4 + memory T-cell subset.
As shown in Fig. 1A ,B, S1, levels of both the surface as well as intracellular expression of CXCR4 appeared to be higher in CD4 + T cells obtained from elderly donors as compared to those from the young. Further, as shown in Fig. 1C , CD4 + CD45RA + naïve T-cell subset appeared to have higher levels of surface expression of CXCR4 relative to CD4 + CD45RO + memory subset, derived from both young and elderly donors. Additionally, irrespective of the age of the donor, intracellular levels of CXCR4 were far greater than those detected on the surface of T cells. To determine whether the observed increase in CXCR4 expression in T cells from the elderly correlated with an overall increase in CXCR4 protein and ⁄ or mRNA expression, we next assessed the protein and mRNA levels of T cells obtained from young and elderly donors were labeled using antibody to CXCR4, followed by Alexa Fluor 488-conjugated secondary antibody staining and then fixed with 2% PFA. Right panel: Intracellular expression of CXCR4 in CD4 + T cells obtained from young and elderly donors. CD4 + T cells obtained from young and elderly donors were fixed using 2% PFA and then permeabilized with 1xPBS buffer containing 0.1% Saponin. Cells were then stained using an antibody to CXCR4, followed by Alexa Fluor 488-conjugated secondary antibody. Cell surface and intracellular expression of CXCR4 were detected by flow cytometry. Cumulative data of percent cells expressing CXCR4 obtained from 10 independent donor pairs are provided. **Denotes statistical significance at P < 0.001. (B). Flow cytometry of CD4 + T cells from young and elderly donors stained for intracellular and extracellular CXCR4 expression, using antibody to CXCR4, followed by secondary antibody coupled to fluorochrome. Representative data from one young (Left panel)) and elderly (Right panel) donor pair are provided. Intracellular CXCR4 staining was carried out using fixed, permeabilized CD4 + T cells, while extracellular staining was carried out on unfixed cells. Minimal impact of aging on the surface expression of CCR5 in resting and activated CD4 + T cells
To evaluate whether the increase in expression of CXCR4 observed in CD4 + T cells from elderly donors was exclusive to this chemokine receptor and not to a generalized increase in the surface expression of all chemokine receptors during aging, we next assessed the expression of CCR5. CCR5 was chosen for the study because it has been demonstrated to be constitutively expressed in T lymphocytes and has been shown to synergize with CXCR4 in controlling the migration of CD14 + monocytes and CD3 + T cells (Desmetz et al., 2007; Contento et al., 2008; Gouwy et al., 2011) . Additionally, CCR5 has also been reported to increase and sustain CXCR4 ligand-induced ERK phosphorylation and activation, necessary for gene transcription and cytokine production in response to CXCL12 (Yopp et al., 2004; Gouwy et al., 2011) . As shown in Fig. 2A ,B, surface expression of CCR5 showed a consistent but minimal increase between both the age groups, under resting and as well as under activated (PMA + Ionomycin) conditions. As CCR5 is known to regulate chemotactic migration in T cells, we next examined the effect of different concentrations of CCL8, ligand for CCR5, on CD4 + T-cell migration using a trans-well assay.
As shown in Fig. 2C , a dose-dependent increase in migration was observed in CD4 + T cells obtained from both young and elderly donor groups, with the dose of 10 nM of CCL8 eliciting the maximum migration index. Thus, employing CCL8 at 10 nM, we next assessed the migration of CD4 + T cells from both young and elderly donors. As shown in Fig. 2D , CD4 + T cells obtained from both young and elderly donors migrated toward CCL8, showing little impact of age on migration. In CD4 + T cells that were pretreated with PMA + Ionomycin, the migration index increased, demonstrating a direct correlation with increased cell surface expression of CCR5. Interestingly, unlike our results obtained in response to CXCL12, the age of the CD4 + T-cell donor had little impact on the ability of CD4 + T cells to migrate toward CCL8. Thus, a specific increase in the surface expression of CXCR4, and not a generalized increase in overall expression of chemokine receptors, is attributable to the increase in CXCL12-dependent migration observed in T cells from the elderly.
Differential ubiquitination of CXCR4 occurs in CD4 + T cells during aging and may contribute to increased surface expression
To understand the molecular mechanism ⁄ s that contributes to the observed increase in CXCR4 surface expression in CD4 + T cells from elderly donors, we next evaluated the stability of CXCR4 expression during aging. In fact, as previous studies have demonstrated that ubiquitination at the C-terminal domain of CXCR4 is required for lysosomemediated receptor degradation, we focused on ubiquitination of CXCR4 (Marchese & Benovic, 2001; Bhandari et al., 2007; Malik & Marchese, 2010; Caballero & Marchese, 2011) . Additionally, previous studies have also shown that ligand-induced stimulation of CXCR4 results in increased . Surface expression of CCR5 in CD4 + T cells from young and elderly donors. CD4 + T cells obtained from young and elderly donors were either left untreated (A) or activated with PMA ⁄ Ionomycin for 12 h (B), stained using antibody to CCR5 followed by Alexa Fluor 555-conjugated secondary antibody. Surface expression of CCR5 was detected by flow cytometry. Cumulative data obtained from a minimum of 8 independent donor pairs are provided. **Denotes statistical significance at P < 0.001; **Denotes statistical significance at P < 0.009. (C). Dose-dependent migration of CD4 + T cells from young and elderly donors to CCL8 gradient. CD4 + T cells (3 · 10 5 ) from young and elderly donors were placed in the upper chamber of a trans-well migration plate (5 lM pore) and allowed to migrate for 4 h at 37°C toward a gradient generated by either 1, 10, 50 or 100 nM of CCL8. The number of migrating cells present in the lower chamber was assessed by Trypan Blue staining, and the percentage of migrating cells is provided. Values represent mean ± SE from four independent donor pairs. ubiquitination, mediated by a complex formed by E3 ubiquitin ligase AIP4, underscoring the importance of ubiquitination (Marchese et al., 2003; Bhandari et al., 2009) . As shown in Fig. 3A ,B, immuno-precipitation of CXCR4 followed by western blot with antibody to CXCR4 demonstrated several CXCR4 isoforms in CD4 + T-cell lysates from both young and elderly donors (3A, long exposure). The appearance of several isoforms of CXCR4 (antibody reactive bands) is in agreement with observations made in other cell types. Interestingly, CXCR4 isoforms at 45, 62 and 100 kDa, appear to be lower in the immunoprecipitates of lysates derived from CD4 + T cells obtained from the elderly relative to those from the young. In contrast, the isoform ⁄ s appearing above 150 kDa is more abundant in the elderly relative to that seen in immunoprecipitates from the young. As the appearance of these isoforms may be attributable to differential ubiquitination of CXCR4, we next tested the lysates for ubiquitin-dependent modification of CXCR4, following immunoprecipitation with anti-CXCR4. As seen in Fig. 3B , CXCR4 is indeed differentially ubiquitinated in lysates obtained from the young, relative to those from the elderly (3B, long exposure). Additionally, the presence of heavily polyubiquitinated CXCR4 in the immunoprecipitates from the elderly, appearing at > 150 kDa molecular weight, but not from the young, suggests the involvement of the proteasome in the accumulation, and perhaps in down-regulating, CXCR4 molecules. As our laboratory has previously reported age-associated deficits in proteasomal catalytic function in T cells from the elderly (Das et al., 2007; Ponnappan et al., 2007; Ponnappan & Ponnappan, 2011) , accumulation of high molecular weight polyubiquitinated-CXCR4 may be an outcome of such a defect. This observation is further supported by independent reports that employed chemical inhibition of the proteasome, resulting in increased surface expression of CXCR4 in lymphocytes. Thus, results presented here demonstrate that alterations in the ubiquitination of CXCR4 and ⁄ or proteasome function may account for the increased surface expression of CXCR4 observed in CD4 + T cells during aging.
Inhibition of USP14 results in increased surface expression of CXCR4
As previous experiments indicated increased polyubiquitinated CXCR4 isoforms occurring in CD4 + T cells from the elderly, implying alteration in the ubquitination ⁄ deubiquitination cycle of CXCR4, we next evaluated the effect of inhibition of a deubiquitinating enzyme, USP14, on the surface expression of CXCR4. We chose to target USP14, because previous studies have reported a critical role for USP14 in CXCR4 degradation and chemotaxis mediated by CXCL12 (Mines et al., 2009) . CD4 + T cells from young and elderly donors were either left untreated or pretreated with a small molecule inhibitor of USP14, IU-1, and then activated with CXCL12. At the end of the treatment, surface expression of CXCR4 was evaluated by flow cytometry employing a CXCR4-specific antibody. As shown in Fig. 4 , increase in the surface expression of CXCR4 upon IU-1 treatment occurred in CD4 + T cells obtained from both young and elderly donors, suggesting that USP14-specific deubiquitination activity is essential for CXCR4 internalization. Interestingly, we also observed that pretreatment with IU-1 partially blocked CXCL12-mediated CXCR4 down-modulation ⁄ degradation in CD4 + T cells from young donors but not in those from the elderly, indicating an age-associated defect in ligand-induced degradation of CXCR4 in CD4 + T cells. Thus, inhibition of USP14 results in increased surface expression of CXCR4 and negatively impacts CXCL12 mediated CXCR4 internalization and degradation, by regulating the ubiquitination ⁄ deubiquitination cycle.
Decreased ligand-induced degradation of CXCR4 in CD4 + T
cells during aging
Upon stimulation with CXCL12, CXCR4 is internalized and sorted through the endosomal compartment, where it is either recycled back to plasma membrane or is degraded. The observed decrease in mono-ubiquitination (A) (B) + T-cell lysates obtained from a pool of 5 young and 5 elderly donors were immunoprecipitated with an antibody to CXCR4. The immunoprecipitate was resolved using SDS-PAGE and detected using an antibody to CXCR4. Representative blot from one immune-precipitation assay is provided. Arrows depict approximate molecular weight of the CXCR4 isoforms derived from molecular weight standards, and approximate number of ubiquitin tags that could account for the increase in molecular weight. (B). Decreased monoubiquitination and increased polyubiquitination (>8Ub-linkages) of CXCR4 in CD4 + T cells, accompanies aging. Cell lysates of CD4 + T cells obtained from 3 independent pools of 5, 3, and 3 young and elderly donors were immunoprecipitated with an antibody to CXCR4. Resolved immunoprecipitates were immunoblotted with antibody to ubiquitin. Long exposure indicates extended exposure of the film to demonstrate the appearance of intense high molecular weight CXCR4 isoforms denoting polyubiquitination. Arrows indicate ubiquitinated species attributable to 1, 3, and 8 ubiquitin linkages and are based on approximately 8.5 kDa increments in molecular weight.
Regulation of CXCR4 expression during aging, S. Cané et al. prompted us to evaluate whether CXCL12-dependent degradation of CXCR4 was also impaired in CD4 + T cells from the elderly. CD4 + T cells obtained from both young and elderly donors were either left untreated or activated with CXCL12 (100 nM) for 1 and 3 h. As shown in Fig. 5A ,B, we observed a time-dependent decrease in CXCR4 levels in the lysates of CD4 + T cells obtained from young donors, but not in those from the elderly, where the levels of CXCR4 appeared to be minimally affected, irrespective of the length of activation with CXCL12. Thus, our results suggest that ligand-dependent CXCR4 degradation is impaired in CD4 + T cells from elderly donors.
Discussion
Chemokine-dependent migration is a fundamental feature of T-cell function that ensures homing of naïve T cells to secondary lymphoid organs and recirculation of memory-effector T cells to the periphery (Friedman et al., 2005; Contento et al., 2008; Bunting et al., 2011) . CXCL12 and its receptor CXCR4 have garnered a great deal of interest because of their central role in inflammation, homeostasis, migration in the immune system, and in a wide variety of cancers because of their increased association with cancer progression and tumor cell proliferation (Zlotnik et al., 2011) . Additionally, the recognition of CXCR4 as a co-receptor for HIV infection has provided greater significance for its expression within T-cell subsets (Feng et al., 1996) . Recent studies on WHIM syndrome, a congenital immune deficiency, have demonstrated mutations of the intracellular carboxy terminus of CXCR4. WHIM leukocytes have enhanced responses to CXCL12 because of receptor desensitization (Bachelerie, 2010) . Thus, any biological process that alters the level and ⁄ or function of chemokine receptors will likely impact the ability of the immune system, not only to mount appropriate responses to invading pathogens, but also to affect immune homeostasis. Limited information regarding changes of chemokine receptors during human aging, coupled together with our previous observation of increased chemotactic migration toward CXCL12 gradient in CD4 + T cells from the elderly, prompted us to evaluate the expression, function and regulation of CXCR4 in CD4 + T cells from young and elderly donors. Here, we provide evidence that CD4 + T cells from the elderly have increased surface expression of CXCR4, which may partly contribute to the increased migration toward a gradient generated by CXCL12, previously described by our laboratory (Cane et al., 2012) . While the overall protein levels of CXCR4 are also significantly increased in CD4 + T cells during aging, the mRNA levels remain unaffected, suggesting a role for posttranslational regulation. Our results of increased CXCR4 expression is in partial agreement with previously published results by Yung and colleagues in a murine model of aging employing splenic lymphocytes (Mo et al., 2003) . To determine whether a generalized up-regulation of chemokine receptor expression accompanies aging, we next evaluated CCR5 expression. Interestingly, we found that, unlike CXCR4, surface expression of CCR5 on CD4 + T cells showed only a minimal increase in cells from the elderly, both under resting conditions, as well as upon activation with PMA ⁄ Ionomycin. Thus, the expression of CXCR4 to a greater extent and CCR5 to a lesser extent was affected by advancing age. As cells exposed to a chemotactic gradient generated by CXCL12 demonstrated increased migratory index in T cells from the elderly, we next assessed migration of T cells toward CCL8, the ligand for CCR5. In a chemotactic gradient generated by CCL8, CD4 + T cells obtained from both young and elderly donors demonstrated similar migratory indices in a + T cells obtained from young and elderly donors were either left untreated or pretreated with IU-1 (50 lM; 4 h), and then either activated with CXCL12 (100 nM; 1 h), or not. T cells were then stained using an antibody to CXCR4, followed by Alexa Fluor 488-conjugated secondary antibody. Surface expression of CXCR4 was detected by flow cytometry. Data obtained from three independent donor pairs are provided. **Denotes statistical significance at P < 0.007; *Denotes statistical significance at P < 0.02. trans-well assay, suggesting that the minimal change in CCR5 expression did not significantly impact migration toward CCL8. These results led us to conclude that the increase in CXCR4 expression with age is not due to a generalized age-associated increase in chemokine receptor expression and function, but rather to a specific increase in CXCR4.
Although, it appears that CXCR4 regulation is altered during aging, the molecular mechanism ⁄ s dictating this change in CXCR4 remains to be fully defined. In keeping with previous reports (Zaitseva et al., 1998; Contento et al., 2008) , our studies in CD4 + T cells obtained from human donors demonstrate the occurrence of different isoforms of CXCR4, based on cross-reactivity with an antibody specific to CXCR4. Our results for the first time demonstrate an age-associated effect on the nature of the detected CXCR4 isoforms. It appears that CXCR4 isoforms with high molecular weights are more abundant in lysates derived from CD4 + T cells from the elderly relative to those from the young. However, it should be noted that not all high molecular weight isoforms are consistently observed in samples from the elderly. The ''ladder-like'' high molecular weight bands observed in the elderly suggested that they might correspond to polyubiquitinated forms of CXCR4. As several studies have shown ubiquitination of CXCR4 on lysine residues located at the C-terminal domain of CXCR4 by the E3 ubiquitin ligase AIP4 is responsible for targeting it to lysosome for degradation, such a modification seemed like a plausible explanation for the occurrence of high molecular weight isoforms (Marchese et al., 2003; Bhandari et al., 2009; Caballero & Marchese, 2011) . Indeed, in agreement with previous reports, we now demonstrate that in CD4 + T cells from young donors, several CXCR4 isoforms are differentially ubiquitinated, with fewer polyubiquitinated isoforms. In contrast, relatively higher levels of polyubiquitinated CXCR4 isoforms are observed in CD4 + T cells from the elderly, lending support to our hypothesis. Although, at this time, it is technically challenging to experimentally discriminate between polyubiquitinated or multiplymonoubiquitinated CXCR4 isoforms, and whether they exhibit K-48 and K-63 ubiquitin linkages, future studies will attempt to address these issues. One probable underlying basis for the increase in polyubiquitinated species of CXCR4 in T cells from the elderly may be attributable to the altered intracellular redox potential in CD4 + T cells during aging coupled with proteasomal dysfunction Ponnappan & Ponnappan, 2011) . This increased polyubiquitinated species may confer stability, resulting in increased surface expression, leading to higher chemotactic migratory index toward CXCL12 gradient. Additionally, our findings of altered kinetics of ligand-mediated degradation of CXCR4 in CD4 + T cells from the elderly, strongly support the contention that mechanisms involved in CXCR4 down-modulation may also be altered during aging. Our studies for the first time unravel a role for the deubiqitinating enzyme USP14, in the ubiquitination ⁄ deubiquitination cycle of CXCR4. These studies further point to an age-associated alteration of the regulation of USP14. Previous reports of USP14 regulation have implicated both inhibition and over-expression of USP14 in increased surface expression of CXCR4 (Mines et al., 2009) . In keeping with this observation, our studies demonstrate that treatment with a small molecule inhibitor of USP14, IU1, results in a significant increase in CXCR4 levels in CD4 + T cells, irrespective of the donor age. Interestingly, increased levels of USP14 are observed in cells from the elderly, relative to those from young donors (data not shown). We believe that this inherent increase in USP14 in T cells may underlie increased CXCR4 expression observed in the elderly. However, it should be noted that the experiments designed in this study fail to discriminate whether USP14-mediated regulation of CXCR4 expression is either direct or indirect. In summary, the observations that emerge from these studies begin to shed light on the underlying basis for the increase in migration observed in CD4 + T cells during aging by primarily focusing on CXCR4 regulation.
The increased expression and altered post-translational ubiquitination of CXCR4 in CD4 + T cells from the elderly, coupled with altered USP14 activity, may result in the retention of CXCR4 on the surface and thus contribute to increased migration toward a chemotactic gradient generated by CXCL12. Given the roles of redox regulation, proteasome and ubiquitination in CXCR4 regulation, further investigations are clearly warranted to dissect the relationships involving these pathways in the context of aging and immune senescence.
Experimental procedures Antibodies and reagents
Horseradish peroxidase-conjugated goat anti-mouse antibody was from BD Biosciences (San Jose, CA, USA). Antibodies to human CCR5, CD4 CD45-RO, and CD4 CD45-RA were from eBiosciences (San Diego, CA). Antibody to b-actin and CXCR4 were from Santa Cruz biotechnology (Santa Cruz, CA, USA). Alexa Fluor 555-conjugated goat anti-mouse secondary antibody and Alexa Fluor 488-conjugated goat anti-rabbit secondary antibody were from Invitrogen (Carlsbad, CA, USA). Antibody to ubiquitin-protein conjugates was from Enzo Life Sciences (Farmingdale, NY, USA). Horseradish peroxidase-conjugated goat anti-rabbit antibody was from Thermo Scientific (Rockford, IL, USA). All fine chemicals, unless otherwise mentioned, were obtained from Sigma-Aldrich (St. Louis, MO, USA). CXCL12 and CCL8 were from ProSpec-Tany Technogene (Rehovot, Israel). Electrophoresis supplies were from Bio-Rad (Hercules, CA, USA). USP14 small molecule inhibitor (IU1) was from BioVision (Mountain View, CA, USA).
Human subjects
Peripheral blood was obtained by venipuncture from healthy young (21-30 years) and elderly (65-89 years) adults enrolled from the greater Little Rock area. Immuno-compromised subjects were excluded, including individuals with asthma and those taking immune-modulating drugs upon consultation with the study geriatrician. Subjects on antibiotics or who self-reported symptoms of recent infection (<3 weeks before enrollment) were excluded. All protocols involving human subjects were approved by the UAMS Institutional Review Board and appropriate informed consents were obtained. Blood draw was performed at the Clinical Research Center (CRC) at UAMS. Western blotting and Immunoprecipitation CD4 + T-cell lysates, equalized for protein levels, were resolved using sodium dodecyl sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE),
T lymphocyte isolation
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For immunoprecipitation studies, precleared cell lysates (200 lg protein) were incubated with antibody to CXCR4 and protein A ⁄ G agarose beads overnight at 4°C with gentle rocking. Protein A ⁄ G beads containing the adsorbed immunoprecipitated complex were washed with RIPA buffer, resuspended in 30 lL of 2X SDS-sample buffer and heated in a boiling water-bath for 5 min. Protein complexes were resolved by SDS-PAGE and subjected to western blot analyses, as detailed previously.
Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR)
Total RNA was isolated using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). Four microgram of total RNA for each sample was reverse-transcribed and the resultant cDNA was amplified using the Bio-Rad iCycler PCR system. Reactions were performed in 96-well PCR plates using 12.5 lL of iQ SYBR Green Supermix (Bio-Rad), forward and reverse primers (0.3 nmol each), and cDNA (3 lL) in a final volume of 25 lL. Amplification parameters were denaturation at 95°C for 10 min followed by 40 cycles at 95°C for 30 s and 60°C for 70 s. Samples were analyzed in duplicate for the expression levels of cxcr4. Housekeeping genes, human b-actin and GAPDH, were used for normalization. Fold induction was calculated after normalization using the DDC T method. Dissociation curves indicated that each reaction consisted of a single reaction product. Genespecific primers were designed by Primer3 software employing human sequences obtained from GenBank. Primer sequences will be provided upon request.
Flow cytometry
For surface staining, CD4 + T cells as well as CD4 + CD45RO + and RA + T-cell subsets were either incubated with antibody to CXCR4 or CCR5 followed by incubation with an antibody conjugated to Alexa Fluor-488 or Alexa Fluor-555, respectively, for 20 min at 4°C. At the end of incubation, cells were washed with ice cold PBS containing 0.1% BSA and fixed with 2% paraformaldehyde (PFA).
Chemotactic migration assay ) either untreated or pretreated with PMA (100 ng ⁄ ml) and Ionomycin (500 nM) for 12 h were resuspended in 100 ll of media containing 0.2% BSA and placed into the upper chamber of a trans-well migration plate (5 lm pore, Costar). In the lower chamber, 600 ll of media containing 0.2% BSA, with or without 10 nM of CCL8, was added and cells were allowed to migrate for 4 h at 37°C. The number of migrated cells was counted following Trypan Blue staining. For doseresponse experiments, CD4 + T cells (3 · 10 5 ) were resuspended in 100 lL of media containing 0.2% BSA and placed into the upper chamber of a trans-well migration plate (5 lm pore, Costar). In the lower chamber, 600 lL of media containing 0.2% BSA with 1, 10, 50, or 100 nM of CCL8 was added and cells were allowed to migrate for 4 h at 37°C. The number of migrated cells was counted following Trypan Blue staining.
Assessment of CXCR4 regulation by ligand and a ubiquitin specific protease inhibitor
To determine ligand-induced degradation of CXCR4, freshly isolated CD4 + T cells from both young and elderly donors were incubated either in the presence or absence of CXCL12 (100 nM) for 1 and 3 h. At the end of incubation, the cells were washed twice with cold 1X PBS and cellular lysates were obtained. Percent degradation relative to control is presented.
To evaluate the impact of USP14 inhibition on CXCR4 protein levels, CD4 + T cells from young and elderly donors were pretreated with IU-1, 50 lM for 4 h, followed by activation with CXCL12 (100 nM) for 1 h. At the end of the incubation, CD4 + T cells were washed twice with cold 0.1% BSA ⁄ PBS and stained with a CXCR4-specific antibody to assess the surface expression of CXCR4.
Statistical analyses
Differences between means of the data generated in the study were analyzed using Student's t-test. Differences were considered significant, if P < 0.05.
Supporting Information
Additional supporting information may be found in the online version of this article:
Fig. S1 Immunofluorescent microscopy of CXCR4 staining in a representative young and elderly donor pair.
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